RxDoctor Payments Data

Dawn Hopper, APRN

Family · Fordyce, ARNPI 1366981151

Payments from drug & device makers

$2,777in general payments, 2019–2025

Across 137 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • Johnson & Johnson$642
  • Pfizer$155
  • Regeneron Healthcare Solutions, Inc.$153
  • UCB, Inc.$100
  • LEO Pharma Inc.$99
  • plus $325 from 6 others

What the payments were for

  • Food & beverage$2,41587%
  • Education$36213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,777 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$349,023
Medicare patients
1,208
Services billed
12,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab71$474,264
StelaraUstekinumab12$250,264
OtezlaApremilast11$62,425
Dupixent PenDupilumab12$50,406
ZoryveRoflumilast20$17,668
Fluocinonide145$6,205
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc236$5,624
Ketoconazole286$4,874
Triamcinolone Acetonide263$3,300
Ciclopirox63$2,382
Tacrolimus15$2,030
CiclopiroxCiclopirox Olamine76$1,764
Doxycycline Hyclate94$1,761
Clindamycin Phosphate39$1,667
Clobetasol Propionate14$1,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$642$250,26412 claims
Arcutis Biotherapeutics, Inc.Zoryve$18$17,66820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Fordyce

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →